Targeted Protein Degradation Phenotypic Studies Using HaloTag CRISPR/Cas9 Endogenous Tagging Coupled with HaloPROTAC3

Elizabeth A Caine1, Sarah D Mahan1, Rebecca L Johnson1

  • 1Promega Corporation, Madison, Wisconsin.

Summary

This study introduces a novel, reversible live-cell knockout method using HaloPROTAC3 to degrade tagged proteins, enabling conditional protein loss for studying gene function and therapeutic targets.